Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are reshaping drug development and reducing reliance on animal testing.
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on…
